Related Articles
Receptor status variation in primary breast cancer and subsequent accessible relapse
PATHOBIOLOGICAL CHARACTERISTICS OF THE 1ST PRIMARY AND RISK OF METACHRONOUS CONTRALATERAL INVASIVE BREAST-CARCINOMA - CLINICAL IMPLICATIONS
Metachronous second primary lung cancer surgically treated five years or more after the initial surgery
High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study
Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III